로딩 중…
지수 로딩 중…
Sinil Pharmaceutical Co., Ltd.
012790· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,260+2.33%
2026-08-04
Financials
Valuation Metrics
Sinil Pharmaceutical Co., Ltd.'s Market Cap is ₩630B. At end of 2025 it was ₩728B. Ranked #1568 of 2,436 in KR market (top 64%), #917 of 1,649 on KOSDAQ (top 56%), #176 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 75%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 63.05B KRW | KR#1,568/2,436 Sec#176/234 |
| Revenue | 82.18B KRW | KR#1,521/2,436 Sec#96/234 |
| Net Income | 6.95B KRW | KR#1,023/2,436 Sec#67/234 |
| Total Assets | 171.86B KRW | KR#1,376/2,436 Sec#107/234 |
| Net Assets | 153.79B KRW | KR#1,089/2,436 Sec#77/234 |
| Employees | 408 | KR#592/2,436 Sec#50/234 |
| Value | ||
| P/E | 9.07x | KR#648/2,436 Sec#32/234 |
| P/B | 0.41x | KR#601/2,436 Sec#19/234 |
| P/S | 0.77x | KR#1,219/2,436 Sec#63/234 |
| EV/EBITDA | 8.11x | KR#469/2,436 Sec#17/234 |
| FCF Yield | 13.48% | KR#506/2,436 Sec#15/234 |
| Profitability | ||
| ROE | 4.52% | KR#1,058/2,436 Sec#78/234 |
| ROA | 4.04% | KR#782/2,436 Sec#68/234 |
| Op. Margin | 8.21% | KR#607/2,436 Sec#54/234 |
| Revenue Growth | 8.41% | KR#991/2,436 Sec#90/234 |
| Earnings Growth | -28.75% | KR#1,103/2,436 Sec#70/234 |
| Financial Health | ||
| Debt Ratio | 111.75% | KR#480/2,436 Sec#65/234 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/234 |
| FCF | 8.50B KRW | KR#752/2,436 Sec#41/234 |
| Cash | 8.32B KRW | KR#1,774/2,436 Sec#150/234 |
| Current Ratio | 5.56x | KR#254/2,436 Sec#50/234 |
| Net Debt/EBITDA | -1.23x | KR#419/2,436 Sec#23/234 |
| Dividend | ||
| Div. Yield | 3.70% | KR#501/2,436 Sec#20/234 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/234 |
| Performance | ||
| 1Y Return | -18.83% | KR#1,214/2,436 Sec#99/234 |
| 1M Return | 0.00% | KR#847/2,436 Sec#66/234 |
| From 52W High | -22.87% | KR#228/2,436 Sec#13/234 |
| 1Y MDD | -29.19% | KR#188/2,436 Sec#11/234 |
| Trading | ||
| Volume | 9,697 shares | KR#2,040/2,436 Sec#199/234 |
| Foreign Own. | 3.36% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 580 KRW | KR#863/2,436 Sec#63/234 |
| BPS | 13,304 KRW | KR#734/2,436 Sec#51/234 |
Company Info
동사는 1971년 설립되어 1999년 코스닥시장에 상장한 중소기업임. 캡슐제, 시럽제, 연고/크림제, 주사제 등 다양한 의약품을 전국 영업망을 통해 의료기관에 공급하며, 다품종 제품 생산 노하우와 우수한 품질관리 시스템을 바탕으로 약 80개 제약사 대상 CDMO사업을 영위하고 있음. 또한 제약기술을 활용한 기능성화장품 및 건강기능식품 통합 브랜드 팜트리를 운영하며 의약외품 사업을 진행하고 있음. 신일제약는 1977년에 설립되었으며 충북 충주시에 본사를 두고 있습니다.